导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.67% | 745/4773 |
| 近一周 | -3.33% | 4071/5462 |
| 近一月 | -8.98% | 4511/5421 |
| 近一季 | -13.20% | 3956/5209 |
| 近半年 | 10.34% | 479/4920 |
| 近一年 | 15.46% | 675/4366 |
| 近两年 | 157.42% | 167/2954 |
| 近三年 | 114.77% | 84/2253 |
| 成立以来 | 93.47% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.06% 4016/4961 |
52.02% 551/5312 |
- - |
- - |
| 2025 | 64.85% 151/4813 |
5.02% 842/3635 |
1.42% 2341/4076 |
54.95% 199/4524 |
-0.11% 2363/4813 |
| 2024 | 20.27% 475/3463 |
-1.28% 1208/2808 |
-2.69% 1229/3014 |
14.26% 2018/3129 |
9.57% 319/3463 |
| 2023 | 10.63% 90/2656 |
36.12% 53/2280 |
-3.01% 731/2385 |
-13.39% 2149/2515 |
-3.25% 639/2655 |
| 2022 | -32.95% 1692/2207 |
-19.54% 1472/1919 |
-2.71% 1788/2016 |
-19.63% 1796/2113 |
6.58% 357/2208 |
| 2021 | 10.20% 438/1822 |
-5.48% 928/1255 |
13.79% 277/1330 |
-7.66% 1074/1466 |
10.97% 95/1822 |
| 2020 | - - |
- - |
- - |
0.94% 1035/1164 |
-0.74% 1083/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 融通人工智能指数(LOF)C VS. 长安沪深300非周期A(740101) |